T1	Procedure 11 34	mechanically ventilated
T2	Temporal 35 44	>72 hours
R1	Has_temporal Arg1:T1 Arg2:T2	
T3	Observation 104 142	risk of iatrogenic probiotic infection
T4	Condition 205 222	immunocompromised
T5	Condition 236 239	HIV
T6	Measurement 245 248	CD4
T7	Value 240 244;249 257	<200 cells/µL
R2	Has_value Arg1:T6 Arg2:T7	
R3	AND Arg1:T5 Arg2:T6	
T8	Procedure 283 312	immunosuppressive medications
T9	Qualifier 275 282	chronic
R4	Has_qualifier Arg1:T8 Arg2:T9	
T10	Drug 320 332	azathioprine
T11	Drug 334 346	cyclosporine
T12	Drug 348 364	cyclophosphamide
T13	Drug 366 376	tacrolimus
T14	Drug 378 390	methotrexate
T15	Drug 392 404	mycofenolate
T16	Drug 406 414	Anti-IL2
*	OR T10 T11 T12 T13 T14 T15 T16
T17	Scope 320 414	azathioprine, cyclosporine, cyclophosphamide, tacrolimus, methotrexate, mycofenolate, Anti-IL2
R5	Subsumes Arg1:T8 Arg2:T17	
T18	Procedure 426 441	transplantation
T19	Procedure 498 510	chemotherapy
T20	Temporal 518 531	last 3 months
R6	Has_temporal Arg1:T19 Arg2:T20	
T21	Condition 533 544	neutropenia
T22	Measurement 546 571	absolute neutrophil count
T23	Value 572 578	< 500]
R7	Has_value Arg1:T22 Arg2:T23	
R8	AND Arg1:T21 Arg2:T22	
T24	Scope 205 579	immunocompromised populations (HIV <200 CD4 cells/µL, those receiving chronic immunosuppressive medications (e.g., azathioprine, cyclosporine, cyclophosphamide, tacrolimus, methotrexate, mycofenolate, Anti-IL2), previous transplantation (including stem cell) at any time, malignancy requiring chemotherapy in the last 3 months, neutropenia [absolute neutrophil count < 500])
R9	Subsumes Arg1:T3 Arg2:T24	
R10	Subsumes Arg1:T4 Arg2:T5	
*	OR T4 T8 T18 T19 T21
T25	Observation 720 751	risk for endovascular infection
T26	Condition 775 798	rheumatic heart disease
T27	Condition 800 824	congenital valve disease
T28	Condition 846 870	congenital heart disease
T29	Qualifier 826 845	surgically repaired
R11	Has_qualifier Arg1:T28 Arg2:T29	
T30	Condition 883 916	cyanotic congenital heart disease
T31	Qualifier 872 882	unrepaired
R12	Has_qualifier Arg1:T30 Arg2:T31	
T32	Procedure 922 941	intracardiac repair
T33	Device 947 966	prosthetic material
R13	AND Arg1:T32 Arg2:T33	
T34	Device 982 1012	bio-prosthetic cardiac valves]
T35	Device 968 978;997 1011	mechanical cardiac valves
*	OR T34 T35
T36	Scope 968 1011	mechanical or bio-prosthetic cardiac valves
R14	Subsumes Arg1:T33 Arg2:T36	
T37	Condition 1034 1046	endocarditis
T38	Device 1058 1078	endovascular devices
T39	Qualifier 1048 1057	permanent
R15	Has_qualifier Arg1:T38 Arg2:T39	
T40	Device 1086 1105	endovascular grafts
T41	Procedure 1113 1135	aortic aneurysm repair
T42	Device 1137 1143	stents
T43	Qualifier 1154 1168	large arteries
R16	Has_qualifier Arg1:T42 Arg2:T43	
T44	Device 1208 1234	inferior vena cava filters
T45	Device 1236 1260	dialysis vascular grafts
T46	Device 1290 1312	hemodialysis catheters
T47	Device 1314 1324	pacemakers
T48	Device 1368 1392	central venous catheters
T49	Device 1394 1427	central venous dialysis catheters
T50	Device 1431 1470	peripherally inserted central catheters
T51	Negation 1483 1486	not
T52	Negation 1602 1605	not
T53	Device 1514 1536	coronary artery stents
T54	Device 1538 1567	coronary artery bypass grafts
T55	Device 1578 1597	neurovascular coils
T56	Negation 1681 1684	not
T57	Condition 1630 1651	mitral valve prolapse
T58	Condition 1655 1676	bicuspid aortic valve
*	OR T57 T58
T59	Scope 1630 1676	mitral valve prolapse or bicuspid aortic valve
R17	Has_negation Arg1:T59 Arg2:T56	
*	OR T55 T54 T53
T60	Scope 1514 1597	coronary artery stents, coronary artery bypass grafts (CABG) or neurovascular coils
R18	Has_negation Arg1:T60 Arg2:T52	
*	OR T48 T49 T50
T61	Device 1472 1477	PICCs
R19	Subsumes Arg1:T50 Arg2:T61	
T62	Scope 1368 1478	central venous catheters, central venous dialysis catheters or peripherally inserted central catheters (PICCs)
R20	Has_negation Arg1:T62 Arg2:T51	
*	OR T62 T60 T59
*	OR T47 T46 T38 T33 T30 T28 T27 T26
T63	Scope 1086 1260	endovascular grafts [e.g., aortic aneurysm repair, stents involving large arteries such as aorta, femorals and carotids], inferior vena cava filters, dialysis vascular grafts
R21	Subsumes Arg1:T38 Arg2:T63	
*	OR T41 T42
*	OR T40 T44 T45
T64	Scope 753 1741	previously documented rheumatic heart disease, congenital valve disease, surgically repaired congenital heart disease, unrepaired cyanotic congenital heart disease, any intracardiac repair with prosthetic material [mechanical or bio-prosthetic cardiac valves], previous or current endocarditis, permanent endovascular devices (e.g., endovascular grafts [e.g., aortic aneurysm repair, stents involving large arteries such as aorta, femorals and carotids], inferior vena cava filters, dialysis vascular grafts), tunnelled (not short-term) hemodialysis catheters, pacemakers or defibrillators. Patients with temporary central venous catheters, central venous dialysis catheters or peripherally inserted central catheters (PICCs) are not excluded and patients with coronary artery stents, coronary artery bypass grafts (CABG) or neurovascular coils are not excluded; patients with mitral valve prolapse or bicuspid aortic valve are not excluded providing they have no other exclusion criteria
R22	Subsumes Arg1:T25 Arg2:T64	
T65	Condition 1788 1806	acute pancreatitis
T66	Qualifier 1781 1787	severe
R23	Has_qualifier Arg1:T65 Arg2:T66	
T67	Negation 1808 1815	without
T68	Measurement 1831 1843	Ranson score
R24	Has_negation Arg1:T68 Arg2:T67	
R25	AND Arg1:T65 Arg2:T68	
T69	Negation 1917 1920	not
T70	Condition 1900 1912	pancreatitis
T71	Qualifier 1883 1887	mild
T72	Qualifier 1891 1899	moderate
*	OR T71 T72
T73	Scope 1883 1899	mild or moderate
R26	Has_scope Arg1:T70 Arg2:T73	
R27	Has_negation Arg1:T70 Arg2:T69	
T74	Device 1970 1991	jejunal feeding tubes
T75	Device 1959 1966;1978 1991	gastric feeding tubes
T76	Condition 2047 2063	contraindication
T77	Procedure 2088 2107	enteral medications
R28	AND Arg1:T76 Arg2:T77	
T78	Non-query-able 2110 2175	Intent to withdraw advanced life support as per the ICU physician
T79	Competing_trial 2178 2259	Previous enrolment in this or current enrolment in a potentially confounding tria
